{"schema_version":"secwatch.filing_event.v1","accession":"0000096943-26-000036","form_type":"8-K","ticker":"TFX","cik":"0000096943","company_name":"TELEFLEX INC","filed_at":"2026-03-27T23:59:59+00:00","discovered_at":"2026-05-14T18:02:38.105343+00:00","generated_at":"2026-05-15T08:46:18.831481+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Teleflex responds to Irenic; reaffirms $1.8B sale proceeds for $1B buyback, $800M debt paydown, $50M cost savings","bullets":["Sale transactions of Acute Care, Interventional Urology, and OEM on track for H2 2026 close.","Expected net proceeds of ~$1.8B after tax to fund $1.0B share repurchase and $800M debt paydown.","Multi-year restructuring targets ~$50M annual pre-tax cost savings by mid-2028.","Board has not rebuffed acquirer approaches; will consider bona fide proposals.","CEO search ongoing; interim CEO Stu Randle leading restructuring plan."],"urls":{"canonical":"https://secwatch.observer/filing/0000096943-26-000036","json":"https://secwatch.observer/filing/0000096943-26-000036.json","markdown":"https://secwatch.observer/filing/0000096943-26-000036.md","text":"https://secwatch.observer/filing/0000096943-26-000036.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/96943/000009694326000036/0000096943-26-000036-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/96943/000009694326000036/tfx-20260327.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T08:46:18.831481+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}